Edition:
United Kingdom

Resverlogix Corp (RVX.TO)

RVX.TO on Toronto Stock Exchange

3.04CAD
10 Dec 2018
Change (% chg)

$-0.07 (-2.25%)
Prev Close
$3.11
Open
$3.08
Day's High
$3.16
Day's Low
$2.94
Volume
166,452
Avg. Vol
80,438
52-wk High
$4.31
52-wk Low
$1.11

Chart for

About

Resverlogix Corp is Canada-based clinical-stage biotechnology company. The Company is developing apabetalone (RVX-208), a molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is the BET inhibitor... (more)

Overall

Beta: 3.51
Market Cap(Mil.): $206.99
Shares Outstanding(Mil.): 114.62
Dividend: --
Yield (%): --

Financials

  RVX.TO Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.65 -- --
ROI: -- 0.28 15.02
ROE: -- 0.94 16.60

Earnings vs. Estimates